Investors in Denali Therapeutics Inc (Symbol: DNLI) saw new options begin trading this week, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...

The first-quarter earnings season for the Medical sector will be in full swing this week as several drugmakers are slated to ...

Norges Bank bought a new position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC.

NASDAQ:DNLI opened at $12.74 on Friday. Denali Therapeutics has a twelve month low of $10.57 and a twelve month high of $33.33. The firm has a market capitalization of $1.85 billion, a price-to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amgen’s product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Kyprolis ...

This means that over the past quarter there has been an increase of insiders selling their shares of DNLI in relation to earlier this year. Most recently, in January 2025, Steve E. Krognes ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...